Zach London on Twitter: "6/ Different heavy and light chains are associated with different malignancies. Get to know which with this handy chart. As for me, my heart beats a little faster
Potential pitfalls of serum free light chain analysis to assess treatment response for multiple myeloma - Abbi - 2016 - British Journal of Haematology - Wiley Online Library
Evaluation of monoclonal gammopathies - Differential diagnosis of symptoms | BMJ Best Practice US
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
The Answer, My Friend, is Flowing in the Blood: How to Monitor Treatment Response in Myeloma
Case 966-- Clinical Chemistry Case
PDF] Serum free light chain ratio, total kappa/lambda ratio, and immunofixation results are not prognostic factors after stem cell transplantation for newly diagnosed multiple myeloma. | Semantic Scholar
Frontiers | Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency?
Immune system - Classes of immunoglobulins | Britannica